AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Faxvine 37.5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Holy Evolution Pharma

Salt Composition

Venlafaxine (37.5mg)

Overview Faxvine 37.5 Tablet ER

Anxifree XR 37.5mg extended-release tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, hyperactivity, poor focus, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Anxifree XR 37.5mg with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even if feeling improved; abruptly stopping treatment may worsen symptoms. Common side effects include queasiness, vomiting, sleep disturbances, reduced appetite, nervousness, bowel irregularity, increased sweating, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or tasks demanding concentration until the effects are known. Most side effects are transient and self-limiting. Consult your doctor if side effects persist or are bothersome. Before starting Anxifree XR 37.5mg, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your physician.

Primary Ingredients of Faxvine 37.5 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Faxvine 37.5 Tablet ER

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Faxvine 37.5 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Faxvine 37.5 Extended-Release Tablet should be administered with a meal.

Common Side effects of Faxvine 37.5 Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Faxvine 37.5 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Faxvine 37.5 mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Faxvine 37.5 Tablet ER works:

Extended-release Faxvine 37.5mg tablets elevate brain concentrations of serotonin and norepinephrine, neurotransmitters vital for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Faxvine 37.5 Tablet ER and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Faxvine 37.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Faxvine 37.5 mg tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Faxvine 37.5 mg Extended-Release tablets due to potential side effects. These side effects can include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving safety.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Extended-release Faxvine 37.5mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Extended-release Faxvine 37.5 mg tablets require careful administration in individuals with hepatic impairment. Dosage modification of Faxvine 37.5 mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Faxvine 37.5 Tablet ER :

Should you forget to take a Faxvine 37.5 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Faxvine 37.5 Tablet ER

LabelValue
Chemical Category Anisole-based Compound
Developing Habits No.
Treatment Category Central Nervous System (CNS)
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Faxvine 37.5 Tablet ER

Yes, Faxvine 37.5 Tablet ER may cause drowsiness. Inform your doctor about any other sleep aids you're using before starting this medication.
Yes. Faxvine 37.5 Tablet ER is a psychotropic medication; these drugs alter mental function, mood, and behavior.
Faxvine 37.5 Tablet ER is not a narcotic. Narcotics are opioid-derived drugs, such as heroin and morphine, that cause drowsiness.
Faxvine 37.5 Tablet ER and XR are identical extended-release medications. Both formulations provide a slow, consistent release of medication, reducing the frequency of dosing.
Taking mirtazapine with Faxvine 37.5 Tablet ER carries a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high body temperature, and coma.
Combining citalopram and Faxvine 37.5 mg ER tablets is risky because both increase serotonin levels, potentially causing life-threatening serotonin syndrome. Symptoms include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication should be considered.
P-glycoprotein effluxes Faxvine 37.5 Tablet ER from the brain; however, Faxvine 37.5 Tablet ER and its metabolite have been shown to inhibit p-glycoprotein.
The extended-release Faxvine 37.5 mg tablet is absorbed in the intestines following hepatic metabolism.
Faxvine 37.5 mg Extended-Release tablets treat generalized depressive disorder. Always consult your physician before use.
Faxvine 37.5 Tablet ER may cause sustained high blood pressure in some patients. Regular blood pressure monitoring is recommended for those taking this medication; dose adjustment or discontinuation may be necessary.
Constipation is a known side effect of Faxvine 37.5 Tablet ER. Increase fiber and water intake; laxatives may also help. Your doctor can provide further guidance on prevention and management. Consult your doctor if constipation persists or worsens.
Yes. Some patients taking Faxvine 37.5 Tablet ER experience weight loss, observed in studies to increase with dosage and duration of treatment. Consult your doctor if this concerns you.
Faxvine 37.5 Tablet ER is not habit-forming.
Switching from capsules to tablets requires your doctor's approval. Altering your medication without professional guidance is risky, as different formulations affect drug release and could compromise treatment effectiveness, causing side effects or treatment failure.
Yes, gabapentin and Faxvine 37.5 Tablet ER can be used together, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Caution is advised.
Desvenlafaxine is the active form of the medication in Faxvine 37.5 Tablet ER.
Faxvine 37.5 Tablet ER isn't FDA-approved for fibromyalgia, although some studies suggest potential benefits. Consult your physician before using it for this condition.
While not FDA-approved for nerve pain, Faxvine 37.5 Tablet ER demonstrates efficacy in some research studies and is currently used off-label for this indication.
Faxvine 37.5 Tablet ER alters brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Faxvine 37.5 Tablet ER without medical supervision; doing so may worsen side effects.
Faxvine 37.5 Tablet ER
48
MRP 58
17% off